COVID-19 Vaccination in Our Transplant Recipients: The Time is Now
While the SARS-CoV-2 pandemic has highlighted many of the failings of our healthcare system and society, there has been one spectacular scientific achievement: within a year of the onset of the pandemic, we now have, and can administer vaccines that effectively prevent serious COVID-19. The rapid development of these vaccines has built upon substantive prior vaccine development focused on other pathogens such as Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Ebola virus.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Saima Aslam, Daniel R. Goldstein, Robin Vos, Andrew E. Gelman, Michelle M. Kittleson, Cameron Wolfe, Lara Danziger-Isakov Source Type: research
More News: Cardiology | COVID-19 | Ebola | Ebola Vaccine | Heart | Heart Transplant | Lung Transplant | MERS | Middle East Health | Pandemics | Respiratory Medicine | SARS | Transplant Surgery | Transplants | Vaccines